Cargando…

Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection

Little is known about the role of the neuropeptide somatostatin (SST) in myocardial ischemia/reperfusion injury and cardioprotection. Here, we investigated the direct cardiocytoprotective effect of SST on ischemia/reperfusion injury in cardiomyocyte cultures, as well as the expression of SST and its...

Descripción completa

Detalles Bibliográficos
Autores principales: Vörös, Imre, Sághy, Éva, Pohóczky, Krisztina, Makkos, András, Onódi, Zsófia, Brenner, Gábor B., Baranyai, Tamás, Ágg, Bence, Váradi, Barnabás, Kemény, Ágnes, Leszek, Przemyslaw, Görbe, Anikó, Varga, Zoltán V., Giricz, Zoltán, Schulz, Rainer, Helyes, Zsuzsanna, Ferdinandy, Péter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602362/
https://www.ncbi.nlm.nih.gov/pubmed/34803662
http://dx.doi.org/10.3389/fphar.2021.663655
_version_ 1784601563264712704
author Vörös, Imre
Sághy, Éva
Pohóczky, Krisztina
Makkos, András
Onódi, Zsófia
Brenner, Gábor B.
Baranyai, Tamás
Ágg, Bence
Váradi, Barnabás
Kemény, Ágnes
Leszek, Przemyslaw
Görbe, Anikó
Varga, Zoltán V.
Giricz, Zoltán
Schulz, Rainer
Helyes, Zsuzsanna
Ferdinandy, Péter
author_facet Vörös, Imre
Sághy, Éva
Pohóczky, Krisztina
Makkos, András
Onódi, Zsófia
Brenner, Gábor B.
Baranyai, Tamás
Ágg, Bence
Váradi, Barnabás
Kemény, Ágnes
Leszek, Przemyslaw
Görbe, Anikó
Varga, Zoltán V.
Giricz, Zoltán
Schulz, Rainer
Helyes, Zsuzsanna
Ferdinandy, Péter
author_sort Vörös, Imre
collection PubMed
description Little is known about the role of the neuropeptide somatostatin (SST) in myocardial ischemia/reperfusion injury and cardioprotection. Here, we investigated the direct cardiocytoprotective effect of SST on ischemia/reperfusion injury in cardiomyocyte cultures, as well as the expression of SST and its receptors in pig and human heart tissues. SST induced a bell-shaped, concentration-dependent cardiocytoprotection in both adult rat primary cardiomyocytes and H9C2 cells subjected to simulated ischemia/reperfusion injury. Furthermore, in a translational porcine closed-chest acute myocardial infarction model, ischemic preconditioning increased plasma SST-like immunoreactivity. Interestingly, SST expression was detectable at the protein, but not at the mRNA level in the pig left ventricles. SSTR1 and SSTR2, but not the other SST receptors, were detectable at the mRNA level by PCR and sequencing in the pig left ventricle. Moreover, remote ischemic conditioning upregulated SSTR1 mRNA. Similarly, SST expression was also detectable in healthy human interventricular septum samples at the protein level. Furthermore, SST-like immunoreactivity decreased in interventricular septum samples of patients with ischemic cardiomyopathy. SSTR1, SSTR2, and SSTR5 but not SST and the other SST receptors were detectable at the mRNA level by sequencing in healthy human left ventricles. In addition, in healthy human left ventricle samples, SSTR1 and SSTR2 mRNAs were expressed especially in vascular endothelial and some other cell types as detected by RNA Scope(®) in situ hybridization. This is the first demonstration that SST exerts a direct cardiocytoprotective effect against simulated ischemia/reperfusion injury. Moreover, SST is expressed in the heart tissue at the peptide level; however, it is likely to be of sensory neural origin since its mRNA is not detectable. SSTR1 and SSTR2 might be involved in the cardioprotective action of SST, but other mechanisms cannot be excluded.
format Online
Article
Text
id pubmed-8602362
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86023622021-11-20 Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection Vörös, Imre Sághy, Éva Pohóczky, Krisztina Makkos, András Onódi, Zsófia Brenner, Gábor B. Baranyai, Tamás Ágg, Bence Váradi, Barnabás Kemény, Ágnes Leszek, Przemyslaw Görbe, Anikó Varga, Zoltán V. Giricz, Zoltán Schulz, Rainer Helyes, Zsuzsanna Ferdinandy, Péter Front Pharmacol Pharmacology Little is known about the role of the neuropeptide somatostatin (SST) in myocardial ischemia/reperfusion injury and cardioprotection. Here, we investigated the direct cardiocytoprotective effect of SST on ischemia/reperfusion injury in cardiomyocyte cultures, as well as the expression of SST and its receptors in pig and human heart tissues. SST induced a bell-shaped, concentration-dependent cardiocytoprotection in both adult rat primary cardiomyocytes and H9C2 cells subjected to simulated ischemia/reperfusion injury. Furthermore, in a translational porcine closed-chest acute myocardial infarction model, ischemic preconditioning increased plasma SST-like immunoreactivity. Interestingly, SST expression was detectable at the protein, but not at the mRNA level in the pig left ventricles. SSTR1 and SSTR2, but not the other SST receptors, were detectable at the mRNA level by PCR and sequencing in the pig left ventricle. Moreover, remote ischemic conditioning upregulated SSTR1 mRNA. Similarly, SST expression was also detectable in healthy human interventricular septum samples at the protein level. Furthermore, SST-like immunoreactivity decreased in interventricular septum samples of patients with ischemic cardiomyopathy. SSTR1, SSTR2, and SSTR5 but not SST and the other SST receptors were detectable at the mRNA level by sequencing in healthy human left ventricles. In addition, in healthy human left ventricle samples, SSTR1 and SSTR2 mRNAs were expressed especially in vascular endothelial and some other cell types as detected by RNA Scope(®) in situ hybridization. This is the first demonstration that SST exerts a direct cardiocytoprotective effect against simulated ischemia/reperfusion injury. Moreover, SST is expressed in the heart tissue at the peptide level; however, it is likely to be of sensory neural origin since its mRNA is not detectable. SSTR1 and SSTR2 might be involved in the cardioprotective action of SST, but other mechanisms cannot be excluded. Frontiers Media S.A. 2021-11-05 /pmc/articles/PMC8602362/ /pubmed/34803662 http://dx.doi.org/10.3389/fphar.2021.663655 Text en Copyright © 2021 Vörös, Sághy, Pohóczky, Makkos, Onódi, Brenner, Baranyai, Ágg, Váradi, Kemény, Leszek, Görbe, Varga, Giricz, Schulz, Helyes and Ferdinandy. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Vörös, Imre
Sághy, Éva
Pohóczky, Krisztina
Makkos, András
Onódi, Zsófia
Brenner, Gábor B.
Baranyai, Tamás
Ágg, Bence
Váradi, Barnabás
Kemény, Ágnes
Leszek, Przemyslaw
Görbe, Anikó
Varga, Zoltán V.
Giricz, Zoltán
Schulz, Rainer
Helyes, Zsuzsanna
Ferdinandy, Péter
Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection
title Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection
title_full Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection
title_fullStr Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection
title_full_unstemmed Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection
title_short Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection
title_sort somatostatin and its receptors in myocardial ischemia/reperfusion injury and cardioprotection
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602362/
https://www.ncbi.nlm.nih.gov/pubmed/34803662
http://dx.doi.org/10.3389/fphar.2021.663655
work_keys_str_mv AT vorosimre somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection
AT saghyeva somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection
AT pohoczkykrisztina somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection
AT makkosandras somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection
AT onodizsofia somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection
AT brennergaborb somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection
AT baranyaitamas somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection
AT aggbence somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection
AT varadibarnabas somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection
AT kemenyagnes somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection
AT leszekprzemyslaw somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection
AT gorbeaniko somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection
AT vargazoltanv somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection
AT giriczzoltan somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection
AT schulzrainer somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection
AT helyeszsuzsanna somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection
AT ferdinandypeter somatostatinanditsreceptorsinmyocardialischemiareperfusioninjuryandcardioprotection